Rib-X Pharmaceuticals, Inc. — Form D
Rib-X Pharmaceuticals, Inc. of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-28. The offering totals $22.0M, of which $5.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-01-28
- Form: D
- Accession: 0001164994-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $22.0M
- Amount sold: $5.5M
- Remaining: $16.5M
- Investors: 11
- Date of first sale: 2011-01-12
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-154520
Issuer
- Name: Rib-X Pharmaceuticals, Inc.
- CIK: 0001164994
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 300 GEORGE STREET, NEW HAVEN, CT, 06511
- Phone: 203-624-5606
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Cecilia Gonzalo | Director | New Haven, CT |
| Jonathan Leff | Director | Ness Ziona, L3 |
| George H Milne | Director | New Haven, CT |
| Mark Leuchtenberger | Director | Herzliya, L3 |
| Mark Leuchtenberger | Executive Officer | Herzliya, L3 |
| Robert Conerly | Director | Southington, CT |
| Robert Conerly | Executive Officer | Southington, CT |
| Jonathan S Leff | Director | Coralville, IA |
| C. Boyd H Clarke | Director | New Haven, CT |
| Cecilia S Gonzalo | Director | New Haven, CT |
| George M Milne, Jr. | Director | New Haven, CT |
| Harry H Penner, Jr. | Director | New Haven, CT |
| Jonathan H Fleming | Director | Boston, MA |
| Peter H Greenleaf | Director | New Haven, CT |
| Raymond H Whitaker | Director | New York, NY |
Other filings by this issuer (2)
More